O. Berwanger

COVID-19-associated ARDS treated with DEXamethasone (CoDEX): study design and rationale for a randomized trial

Á. Avezum, R. Lopes, F. Machado, 2020, medRxiv.

The Brazilian Cardioprotective Nutritional Program to reduce events and risk factors in secondary prevention for cardiovascular disease: study protocol (The BALANCE Program Trial).

P. Zuchinali, A. Marcadenti, A. Caldas, 2016, American heart journal.

Dapagliflozin in patients with critical illness: rationale and design of the DEFENDER study

M. Dracoulakis, G. Westphal, A. Serpa-Neto, 2023, Critical care science.

Dapagliflozin for Critically Ill Patients With Acute Organ Dysfunction: The DEFENDER Randomized Clinical Trial.

G. Westphal, T. Corrêa, A. Serpa-Neto, 2024, JAMA.

Study Design The Anti-Coronavirus Therapies (ACT) Trials: Design, Baseline Characteristics, and Challenges

P. Pais, A. Dans, H. Beresh, 2022 .

Study Design The Anti-Coronavirus Therapies (ACT) Trials: Design, Baseline Characteristics, and Challenges

P. Pais, A. Dans, H. Beresh, 2022 .

Novel Tissue Factor Inhibition for Thromboprophylaxis in COVID-19: Primary Results of the ASPEN-COVID-19 Trial

Ian A. Carroll, D. Morrow, M. Effron, 2023, Arteriosclerosis, thrombosis, and vascular biology.